Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease-Reference-Cited by-同舟云学术

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

Published:2000-07 Issue:1 Volume:110 Page:139-146
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Van Wering Elisabeth R.,Van der Linden-Schrever Birgit E. M.,Szczepański Tomasz,Willemse Marja J.,Baars Ed A.,Van Wijngaarde-Schmitz Hanne M.,Kamps Willem A.,Van Dongen Jacques J. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.02143.x/fullpdf

Reference41 articles.

1. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results;Beishuizen;Leukemia,1993

2. Immunologic rebound after cessation of long-term chemotherapy in acute leukemia;Borella;Blood,1972

4. B-cell precursors in normal pediatric bone marrow;Caldwell;American Journal of Clinical Pathology,1991

5. Detection of minimal residual disease in acute leukemia: by flow cytometry;Campana;Cytometry,1999

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update;Indian Journal of Hematology and Blood Transfusion;2023-09-16

2. Flow Cytometric MRD Assessment in Acute Lymphoblastic Leukemias;Indian Journal of Medical and Paediatric Oncology;2023-04-17

3. Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings;Indian Journal of Hematology and Blood Transfusion;2023-03-30

4. Recovery of lymphocyte subpopulations is incomplete in the long‐term setting in pediatric solid tumor survivors;Pediatrics International;2022-01

5. Prophylaxis and Treatment of Central Nervous System (CNS) Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022